Miss GEVA's $56.63 Offering But Think It's A Buy At $55?

Looking back to 3 days ago, Synageva BioPharma Corp (NASD: GEVA) priced a 2,750,000 share secondary stock offering at $56.63 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Friday, the stock is now 9.6% above the offering price.